SCHEMBL20047572

SCHEMBL20047572

CCC(C)(C)C1CCCC(C(=O)OC)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HSD17B10 Q99714 1/20 0.38
FKBP1A P62942 1/20 0.37
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
BTK Q06187 1/20 0.35
GAA P10253 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM3 P20309 1/20 0.34
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20043197 0.83 CHRNB2 (0.43) ALDH1A1SMN1; SMN2HSD17B10CHRNB2CHRNA4
SCHEMBL20351887 0.83 CHRNB2 (0.43) ALDH1A1SMN1; SMN2HSD17B10CHRNB2CHRNA4
SCHEMBL20047644 0.83 CHRNB2 (0.43) ALDH1A1SMN1; SMN2HSD17B10CHRNB2CHRNA4
SCHEMBL4020718 0.80 CTSD (0.39) ALDH1A1SMN1; SMN2HSD17B10FKBP1ACHRNB2
SCHEMBL15443019 0.78 SMN1; SMN2 (0.40) ALDH1A1SMN1; SMN2CHRNB2CHRNA4CHRNB4
SCHEMBL86929 0.76 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2CHRNB2CHRNA4CHRNB4
SCHEMBL62434 0.76 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2CHRNB2CHRNA4CHRNB4
SCHEMBL4030544 0.76 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2FKBP1ACHRNB2CHRNA4
SCHEMBL3942643 0.76 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2FKBP1ACHRNB2CHRNA4
Hydrochloric Acid SCHEMBL27884321 0.75 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2CHRNB2CHRNA4CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof GPBAR1, SLC10A1, NR1H4 ALDH1A1 1577/4885SMN1; SMN2 4455/4885HSD17B10 572/4885
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF GPBAR1, SLC10A1, NR1H4 ALDH1A1 1577/4885SMN1; SMN2 4455/4885HSD17B10 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.